SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-16-000064
Filing Date
2016-11-07
Accepted
2016-11-07 16:32:53
Documents
41
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a9301610qaxovant.htm 10-Q 744642
2 EXHIBIT 31.1 a93016exhibit311.htm EX-31.1 9324
3 EXHIBIT 31.2 a93016exhibit312.htm EX-31.2 9407
4 EXHIBIT 32.1 a93016exhibit321.htm EX-32.1 5781
5 EXHIBIT 32.2 a93016exhibit322.htm EX-32.2 5861
  Complete submission text file 0001636050-16-000064.txt   2152645

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axon-20160930.xml EX-101.INS 210077
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20160930.xsd EX-101.SCH 20328
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20160930_cal.xml EX-101.CAL 38223
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20160930_def.xml EX-101.DEF 61464
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20160930_lab.xml EX-101.LAB 255281
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20160930_pre.xml EX-101.PRE 134879
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 161978563
SIC: 2834 Pharmaceutical Preparations